Identification of Potential Biomarkers and Biological Pathways in Juvenile Dermatomyositis Based on miRNA-mRNA Network

Table 3

Differential expression of mRNAs enrichment pathway.

Pathway	Gene number	value corrected with Bonferroni	Gene list
Epstein–Barr virus infection	14	0.000006091	CD19, CXCL10, DDX58, HLA-A, HLA-B, HLA-C, HLA-F, HLA-G, IRF9, ISG15, OAS1, OAS2, OAS3, STAT1
Hepatitis C	11	0.000101620	CXCL10, DDX58, IFIT1, IRF9, MX1, OAS1, OAS2, OAS3, RSAD2, STAT1, TLR3
Measles	8	0.004296090	DDX58, IRF9, MX1, OAS1, OAS2, OAS3, STAT1, TNFSF10
Influenza A	14	0.000000839	CCL2, CCL5, CXCL10, DDX58, IRF9, MX1, OAS1, OAS2, OAS3, PYCARD, RSAD2, STAT1, TLR3, TNFSF10
Type I diabetes mellitus	5	0.003325171	HLA-A, HLA-B, HLA-C, HLA-F, HLA-G
Autoimmune thyroid disease	5	0.006558777	HLA-A, HLA-B, HLA-C, HLA-F, HLA-G
Allograft rejection	5	0.002068987	HLA-A, HLA-B, HLA-C, HLA-F, HLA-G
Graft-versus-host disease	5	0.002818762	HLA-A, HLA-B, HLA-C, HLA-F, HLA-G
Viral myocarditis	5	0.008802414	HLA-A, HLA-B, HLA-C, HLA-F, HLA-G